Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutationsDavid S P Tan, Christian Rothermundt, Karen Thomas, et al.
BJU International|November 20, 2008
Sexual activity and prostate cancer risk in men diagnosed at a younger agePolyxeni Dimitropoulou, Artitaya Lophatananon, Douglas Easton, et al.
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
British Journal of Cancer|April 10, 2026
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancerKaroline Kondrup, Laura Iisager, Paul Vinu Salachan, et al.
Histopathology|December 17, 2009
Overexpression of RAD51 occurs in aggressive prostatic cancerAnita Mitra, Charles Jameson, Yolanda Barbachano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Patterns of recurrence after prostate bed radiotherapyDouglas H Brand, Joanna I Parker, David P Dearnaley, et al.
Molecular Cancer Therapeutics|May 8, 2007
p53 therapy in a patient with Li-Fraumeni syndromeNeil Senzer, John Nemunaitis, Michael Nemunaitis, et al.
The Journal of Molecular Diagnostics : JMD|January 1, 2008
Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arraysSameer Jhavar, Alison Reid, Jeremy Clark, et al.
Oncogene|June 9, 2004
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeChristopher S Foster, Alison Falconer, Andrew R Dodson, et al.
Pageof 14